Suramin reduces infarct volume in a model of focal brain ischemia in rats

Experimental Brain Research

Volumn 147, Issue 3, 2002, Pages 353-359

  Kharlamov, Alexander ^a   Jones, Stephen C ^a   Kim, Kyle D ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Adenosine; Infarction; Middle cerebral artery occlusion; Neuroprotection; Pre treatment

Indexed keywords

PURINERGIC RECEPTOR BLOCKING AGENT; S 2671; SURAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INFUSION PUMP; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; IMMUNOHISTOCHEMISTRY; INFARCTION; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; REGIONAL BLOOD FLOW; SURAMIN;

EID: 0036431590     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-002-1251-1     Document Type: Article

References (52)

1. 3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin. NeuroReport 7:69-72
2. Balcar VJ, Li Y, Killinger S, Bennett MR (1995b) Autoradiography of P2x ATP receptors in the rat brain. Br J Pharmacol 115:302-306
3. Barnard EA, Burnstock G, Webb TE (1994) G protein-coupled receptors for ATP and other nucleotides: A new receptor family. Trends Pharmacol Sci 15:67-70
4. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17:472-476
5. Belayev L, Busto R, Zhao W, Ginsberg MD (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739:88-96
6. Bradbury MW (1993) The blood-brain barrier. Exp Physiol 78:453-472
7. Buchan AM, Xue D, Slivka A (1992) A new model of temporary focal neocortical ischemia in the rat. Stroke 23:273-279
8. Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509-581
9. Burnstock G (1990) Overview. Purinergic mechanisms. Ann N Y Acad Sci 603:1-17
10. Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B, Delaney PM (2000) A novel, rapid, computerised method for quantitation of neuronal damage in a rat model of stroke. J Neurosci Methods 102:53-60
11. Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR (1996) A prospective study of suramin-induced peripheral neuropathy. Brain 119:2039-2052
12. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD (1986) A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 17:738-743
13. Dawson DA, Hallenbeck JM (1996) Acute focal ischemia-induced alterations in MAP2 immunostaining: Description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J Cereb Blood Flow Metab 16:170-174
14. Dunn PM, Blakeley AG (1988) Suramin: A reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol 93:243-245
15. Edwards FA, Gibb AJ, Colquhoun D (1992) ATP receptor-mediated synaptic currents in the central nervous system. Nature 359:144-147
16. Evans RJ, Derkach V, Surprenant A (1992) ATP mediates fast synaptic transmission in mammalian neurons. Nature 357:503-505
17. Fieber LA, Adams DJ (1991) Adenosine triphosphate-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia. J Physiol 434:239-256
18. Garcia JH, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J, Chen S, Chopp M (1993) Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 142:623-635
19. Hawking F (1978) Suramin: With special reference to onchocerciasis. Adv Pharmacol Chemother 15:289-322
20. Horiuchi T, Dietrich HH, Tsugane S, Dacey RG Jr (2001) Analysis of purine- and pyrimidine-induced vascular responses in the isolated rat cerebral arteriole. Am J Physiol Heart Circ Physiol 280:H767-H776
21. Horne MK, Stein CA, LaRocca RV, Myers CE (1988) Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood 71:273-279
22. Horne MK, Wilson OJ, Cooper M, Gralnick HR, Myers CE (1992) The effect of suramin on laboratory tests of coagulation. Thromb Haemost 67:434-439
23. Hoyle CH, Knight GE, Burnstock G (1990) Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol 99:617-621
24. Hsu SM, Raine L (1981) Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29:1349-1353
25. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q (1999) Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 100:861-868
26. Hu W, Kharlamov A, Wang Y, Perez-Trepichio AD, Jones SC (2000) Directed sampling for electrolyte analysis and water content of micro-punch samples shows large differences between normal and ischemic rat brain cortex. Brain Res 868:370-375
27. Humphrey PP, Buell G, Kennedy I, Khakh BS, Michel AD, Surprenant A, Trezise DJ (1995) New insights on P2X purinoceptors. Naunyn Schmiedebergs Arch Pharmacol 352:585-596
28. Jones SC, Radinsky CR, Furlan AJ, Chyatte D, Perez-Trepichio AD (1999) Cortical NOS inhibition raises the lower limit of cerebral blood flow-arterial pressure autoregulation. Am J Physiol Heart Circ Physiol 276:H1253-H1262
29. Khakh BS, Michel A, Humphrey PP (1994) Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens. Eur J Pharmacol 263:301-309
30. Kharlamov A, Kim DK, Jones SC (2001) Early visual changes in reflected light on non-stained brain sections after focal ischemia mirror the area of ischemic damage. J Neurosci Methods 111:67-73
31. Leff P, Wood BE, O'Connor SE (1990) Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery. Br J Pharmacol 101:645-649
32. Lin T-N, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-121
33. 2+ signals mediated by P2X-type purinoceptors in cultured cerebellar Purkinje cells. J Neurosci 18:1704-1712
34. 14C]suramin in tissues of male rats following a single intravenous dose. Life Sci 67:1847-1857
35. Olson JJ, Polk DM, Reisner A (1994) The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma. Neurosurgery 34:297-308
36. Ong WY, Motin LG, Hansen MA, Dias LS, Ayrout C, Bennett MR, Balcar VJ (1997) P2 purinoceptor blocker suramin antagonises NMDA receptors and protects against excitatory behaviour caused by NMDA receptor agonist (RS)-(tetrazol-5-yl)-glycine in rats. J Neurosci Res 49:627-638
37. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, Graham DI (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry 50:402-410
38. Pettigrew LC, Holtz ML, Craddock SD, Minger SL, Hall N, Geddes JW (1996) Microtubular proteolysis in focal cerebral ischemia. J Cereb Blood Flow Metab 16:1189-1202
39. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
40. Salgado AV, Jones SC, Furlan AJ, Korfali E, Marshall SA, Little JR (1989) Bimodal treatment with nimodipine and low-molecular-weight dextran for focal cerebral ischemia in the rat. Ann Neurol 26:621-627
41. Salter MW, Hicks JL (1994) ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord. J Neurosci 14:1563-1575
42. Shibuya I, Tanaka K, Hattori Y, Uezono Y, Harayama N, Noguchi J, Ueta Y, Izumi F, Yamashita H (1999) Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J Physiol (Lond) 514:351-367
43. Sima B, Macdonald L, Marton LS, Weir B, Zhang J (1996) Effect of P2-purinoceptor antagonists on hemolysate-induced and adenosine 5′-triphosphate-induced contractions of dog basilar artery in vitro. Neurosurgery 39:815-821
44. Stern MD (1975) In vivo evaluation of microcirculation by coherent light scattering. Nature 254:56-58
45. Surprenant A, Buell G, North RA (1995) P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18:224-229
46. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293
47. Takano S, Gately S, Engelhard H, Tsanaclis AM, Brem S (1994) Suramin inhibits glioma cell proliferation in vitro and in the brain. J Neurooncol 21:189-201
48. Trezise DJ, Kennedy I, Humphrey PP (1994) The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by α,β-methylene adenosine 5′-triphosphate. Br J Pharmacol 112:282-288
49. x receptor for extracellular ATP. Nature 371:516-519
50. Voogd TE, Vansterkenburg EL, Wilting J, Janssen LH (1993) Recent research on the biological activity of suramin. Pharmacol Rev 45:177-203
51. Wang Y, Hu W, Perez-Trepichio AD, Ng TC, Furlan AJ, Majors AW, Jones SC (2000) Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke 31:1386-1392
52. Yang Y, Shuaib A, Li Q, Siddiqui MM (1998) Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res 804:169-176